Clinical Trial Update: DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors [EARLY_Phase 1]

View source ↗

Summary

Early-phase imaging trial evaluating DSC-MRI with ferumoxytol and DCE-MRI with gadolinium to assess vascular properties in pediatric brain tumor patients; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Brain Neoplasm

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)
• Gadolinium-based contrast agent (gadolinium-based contrast agent)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Childhood Brain Neoplasm, Recurrent Childhood Brain Neoplasm | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2017-05-23